CSETF JP JPY INAV logo

7DT7 - CSETF JP JPY INAV News Story

¥16331.41 386.2  2.4%

Sector
Size
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 1039

iShares VII Japan U£ - Net Asset Value(s)

Mon 6th July, 2020 7:10am
RNS Number : 0734S
iShares VII MSCI Japan UCITS (Acc)£
06 July 2020
 

FUND:

iShares MSCI Japan UCITS ETF USD (Acc)

DEALING DATE:

3-Jul-20

NAV PER SHARE:

Official NAV GBP 119.341959

   

USD (Equivalent) 148.789666

NUMBER OF SHARES IN ISSUE:

2,432,322

CODE:

CSJP LN

ISIN:

IE00B53QDK08

DISCLAIMER:

All information provided by BlackRock is purely of an indicative nature and subject to change without notice at any time. The information is for guidance only and does not represent an offer, investment advice or any kind of financial service. Although BlackRock has obtained the information provided from sources that should be considered reliable, BlackRock cannot guarantee its accuracy, completeness or that it is fit for any particular purpose. The information provided does not confer any rights.

 

Past performance is not a guide to future performance.  The value of investments and the income from them can fall as well as rise and is not guaranteed.  You may not get back the amount originally invested.  Changes in the rates of exchange between currencies may cause the value of investments to diminish or increase.  Fluctuation may be particularly marked in the case of a higher volatility fund or segregated account and the value of an investment may fall suddenly and substantially.  Levels and basis of taxation may change from time to time. iShares® and BlackRock® are registered trademarks of BlackRock, Inc., or its subsidiaries in the United States and elsewhere.

 

© 2020 BlackRock Advisors (UK) Limited, authorised and regulated by the Financial Conduct Authority.  Registered office: 12 Throgmorton Avenue, London, EC2N 2DL.  Tel: 020 7743 3000.  Registered in England No. 00796793.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NAVUPUPWMUPUUUQ
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.